Non-Hodgkin's Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas (NCT02581631) | Bristol-Myers Squibb | 2016-02-11 |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System (NCT00520130) | National Cancer Institute (NCI) | 2007-10-30 |
Track Non-Hodgkin's Disease automatically
Every clearance here is in the API, with alerts when new ones post.